Krebs Biochemicals Industries Ltd vs Par Drugs Chemicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Krebs Biochemicals & Industries Ltd is ₹ 57.85 as of 15 May 15:30 . The P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Par Drugs & Chemicals Ltd changed from 6.6 on March 2021 to 7.8 on March 2025 . This represents a CAGR of 3.40% over 5 years The Market Cap of Krebs Biochemicals & Industries Ltd changed from ₹ 174.33 crore on March 2021 to ₹ 144 crore on March 2025 . This represents a CAGR of -3.75% over 5 yearsThe Market Cap of Par Drugs & Chemicals Ltd changed from ₹ 76.17 crore on March 2021 to ₹ 104.5 crore on March 2025 . This represents a CAGR of 6.53% over 5 years The revenue of Krebs Biochemicals & Industries Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 7.28 crore. This represent the decline of -100% The revenue of Par Drugs & Chemicals Ltd for the Mar '26 is ₹ 19.97 crore as compare to the Dec '25 revenue of ₹ 30.67 crore. This represent the decline of -34.89% The ebitda of Krebs Biochemicals & Industries Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0.3 crore. This represent the decline of -100% The ebitda of Par Drugs & Chemicals Ltd for the Mar '26 is ₹ 1.8 crore as compare to the Dec '25 ebitda of ₹ 7.39 crore. This represent the decline of -75.64% The net profit of Krebs Biochemicals & Industries Ltd changed from ₹ -5.17 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Par Drugs & Chemicals Ltd changed from ₹ 2.53 crore to ₹ 0.85 crore over 8 quarters. This represents a CAGR of -42.04% The Dividend Payout of Krebs Biochemicals & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Par Drugs & Chemicals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Limited was initially incorporated as 'Krebs Biochemicals Limited' in 1991.
The name of the Company was changed from Krebs Biochemicals Limited to Krebs Biochemicals & Industries Limited effected from November 21, 2003.
Promoted by R T Ravi, Company engages in manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. The Company develops commercially viable biotech processes for application in medicine, agriculture and industry.
Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA.

About Par Drugs & Chemicals Ltd

Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat on 26 February 1999.
Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018. The Company began in 1982 under the vision of the founder, Late Shri Vallabhbhai J. Savani.
The Company discontinued its existing pharmaceutical and chemical operations and diversified into an entirely new vertical line of business.
With shareholder approval, the Company is investing in real estate & construction, clean & renewable energy, and capital markets. At present, Company is engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets.

FAQs for the comparison of Krebs Biochemicals & Industries Ltd and Par Drugs & Chemicals Ltd

Which company has a larger market capitalization, Krebs Biochemicals & Industries Ltd or Par Drugs & Chemicals Ltd?

Market cap of Krebs Biochemicals & Industries Ltd is 120 Cr while Market cap of Par Drugs & Chemicals Ltd is 103 Cr

What are the key factors driving the stock performance of Krebs Biochemicals & Industries Ltd and Par Drugs & Chemicals Ltd?

The stock performance of Krebs Biochemicals & Industries Ltd and Par Drugs & Chemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Krebs Biochemicals & Industries Ltd and Par Drugs & Chemicals Ltd?

As of May 18, 2026, the Krebs Biochemicals & Industries Ltd stock price is INR ₹55.71. On the other hand, Par Drugs & Chemicals Ltd stock price is INR ₹83.98.

How do dividend payouts of Krebs Biochemicals & Industries Ltd and Par Drugs & Chemicals Ltd compare?

To compare the dividend payouts of Krebs Biochemicals & Industries Ltd and Par Drugs & Chemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.